Josh Woolley MD/PhD
trpr-ucsf.bsky.social
Josh Woolley MD/PhD
@trpr-ucsf.bsky.social
Associate Prof and psychiatrist. Studying psychopharmacology including psychedelics and oxytocin. Director of Translational Psychedelic Research (TrPR) Program @UCSF
A family of vampires when they are in a family unit. A fang or vein or drip or suck or seduction or venipuncture of vampires when it is just a group of vampires. Votes?
November 13, 2025 at 7:26 PM
In my experience, scientists would rather use each others toothbrushes than nomenclature.
September 29, 2025 at 2:31 PM
Does it model prop 13? Racism? Nimbyism?
September 8, 2025 at 2:28 PM
No it can’t!
August 30, 2025 at 6:42 AM
New CDC guidelines announce absence of evidence is now evidence of absence.
August 29, 2025 at 1:41 AM
Any evidence these nams are any more reliable? Seems like a wishful proposition. And what about things like potential organ damage or cancer or just intoxication from a drug. Are those outcomes not reproducible? Behavior is finicky but haven’t animal models been critical for mod
medicine?
July 8, 2025 at 4:14 AM
Yes.
July 7, 2025 at 9:44 AM
This is all terrible and disturbing. But I do wonder who you are as it seems you are anonymous?
July 2, 2025 at 3:54 PM
My family always called it “prepared ham”
June 5, 2025 at 12:33 PM
I said this on cnn recently. urldefense.com/v3/__https:/...
CNN News Central - Dr. Josh Woolley
Powered by SnapStream Cloud Sharing
urldefense.com
May 31, 2025 at 5:59 PM
The retreat owed much of its clarity and depth to Dr. Gisele Fernandes, our Director of Psychedelic Facilitation, who held the space with care and intention.

Grateful for the whole line—and for the chance to keep moving with it.
May 28, 2025 at 8:25 PM
TrPR was formally named in 2019, but its roots go back much further. What started as a single trial has grown into a full-spectrum clinical research program.
May 28, 2025 at 8:25 PM
In 2015, there was one study. Now there are many—spanning depression, pain, neurodegeneration, eating disorders, and active-duty military—using psilocybin, psilocin, MDMA, and ketamine to explore new paths in treatment and understanding.
May 28, 2025 at 8:25 PM